Account
Insider Insights
01.11.2022
Germany – Is digitisation the gateway to better ...

Digitisation is thought to contribute significant improvements in knowledge generation in drug devel...

Read more
Publications
19.10.2022
ISPOR 2022: Changing landscape of Orphan Drug Reim...

We compare the rates of positive reimbursement decisions in England and EU4 for orphan drugs approve...

Read more
Insider Insights
18.10.2022
US Pharma Amylyx in hot water over exorbitant pric...

Amylyx has set the annual price of the ALS drug to $158,000, whereas ICER have suggested the drug sh...

Read more
Insider Insights
11.07.2022
New pharmaceutical updated cost containment measur

This updated bill contains some similar measures to those proposed in March as well as some addition...

Read more
News
29.06.2022
PMA Insights: Week 26

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Insider Insights
27.06.2022
EURORDIS release joint statement on patient access

They came up with six proposals, split into three subgroups, aimed at addressing the key barriers to...

Read more
Insider Insights
21.06.2022
Sweden TLV considers cost containment measures

According to the TLV, “The prices of medicines that have been on the market between 5 and 15 years...

Read more
Insider Insights
26.05.2022
New pilot project which delays reimbursement for o

Under ODAP, a protocol is drawn up “with criteria for starting, stopping and effect of a medicine....

Read more
Insider Insights
20.04.2022
Access to cancer drugs

According to the report, the financing of cancer drugs in Spain is “very high” with 90% of oncol...

Read more
News
06.04.2022
PMA Insights: Week 14

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.